Regeneron Pharmaceuticals Inc (REGN)
962.20
-4.10
(-0.42%)
USD |
NASDAQ |
Mar 28, 16:00
962.38
+0.18
(+0.02%)
Pre-Market: 20:00
Regeneron Pharmaceuticals 1 Year Total Returns (Daily): 16.35% for March 28, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
March 28, 2024 | 16.35% |
March 27, 2024 | 17.78% |
March 26, 2024 | 17.51% |
March 25, 2024 | 17.21% |
March 22, 2024 | 28.74% |
March 21, 2024 | 27.41% |
March 20, 2024 | 27.36% |
March 19, 2024 | 28.89% |
March 18, 2024 | 28.39% |
March 15, 2024 | 26.85% |
March 14, 2024 | 25.07% |
March 13, 2024 | 28.33% |
March 12, 2024 | 29.93% |
March 11, 2024 | 29.11% |
March 08, 2024 | 30.01% |
March 07, 2024 | 25.78% |
March 06, 2024 | 24.57% |
March 05, 2024 | 23.86% |
March 04, 2024 | 24.62% |
March 01, 2024 | 27.57% |
February 29, 2024 | 27.05% |
February 28, 2024 | 29.88% |
February 27, 2024 | 31.09% |
February 26, 2024 | 30.69% |
February 23, 2024 | 29.16% |
Date | Value |
---|---|
February 22, 2024 | 28.98% |
February 21, 2024 | 27.64% |
February 20, 2024 | 26.46% |
February 16, 2024 | 28.75% |
February 15, 2024 | 26.89% |
February 14, 2024 | 25.67% |
February 13, 2024 | 23.10% |
February 12, 2024 | 25.01% |
February 09, 2024 | 28.02% |
February 08, 2024 | 26.25% |
February 07, 2024 | 21.89% |
February 06, 2024 | 20.10% |
February 05, 2024 | 19.56% |
February 02, 2024 | 25.82% |
February 01, 2024 | 26.36% |
January 31, 2024 | 24.30% |
January 30, 2024 | 30.32% |
January 29, 2024 | 28.67% |
January 26, 2024 | 26.64% |
January 25, 2024 | 28.02% |
January 24, 2024 | 30.35% |
January 23, 2024 | 30.78% |
January 22, 2024 | 30.59% |
January 19, 2024 | 30.44% |
January 18, 2024 | 28.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-32.65%
Minimum
Sep 27 2019
120.8%
Maximum
Jul 20 2020
21.52%
Average
16.82%
Median
Mar 14 2023
1 Year Total Returns (Daily) Benchmarks
Vertex Pharmaceuticals Inc | 33.44% |
Eli Lilly and Co | 132.3% |
Pfizer Inc | -26.98% |
AbbVie Inc | 19.71% |
Puma Biotechnology Inc | 115.9% |